Joseph Grzymski

Nov 20, 2024 | nature.com | Daniel Judge |Pamala A Pawloski |Joseph Grzymski |Nicole Washington |Alexandre Bolze

AbstractNatural HbA1c levels in GCK Maturity-onset diabetes of the young (GCK-MODY) patients often sit above the diagnostic threshold for type 2 diabetes (T2D). Treatments to lower HbA1c levels show reduced effectiveness in these individuals, yet in case studies to date, GCK-MODY patients often evade secondary T2D complications.

Mar 20, 2024 | cell.com | Elizabeth T. Cirulli |Alexandre Bolze |Daniel Judge |Joseph Grzymski

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Mar 14, 2023 | rgj.com | Joseph Grzymski

This opinion column was submitted by Dr. Joseph J. Grzymski, a research professor in the Center for Genomic Medicine at DRI and the chief scientific officer of Renown Health. A great thing is happening on E. 4th Street near the Nevada Cares Campus: Northern Nevada HOPES is building a new clinic to serve more people in need of basic health care. Why is this a great thing and why is this happening?